We look forward to attending the 2018 BIO International Convention at the Boston Convention and Exhibition Center June 4-7th.
Over the last 5 years, NDA Group has supported the approval of over 40% of new medicinal products in the EU and among our FDA advisory committee clients 80% have achieved product approval.
We work across a range of disease areas including oncology, hematology, infectious disease, metabolic and immunologic disorders and CNS and have supported the development of over 50 rare disease programs.
The following individuals will be representing NDA Group as we participate in a week of networking and education with 16,000+ attendees from 74 countries. If you would like to arrange a face-to-face meeting with the NDA Group Team, please contact Barbara Clendenen, who will be happy to assist email@example.com
To read more about the event click here.